2025 Q3 No --10-31 false false 0001813744 0001813744 2024-11-01 2025-07-31 0001813744 2025-09-23 0001813744 2025-07-31 0001813744 2024-10-31 0001813744 2025-05-01 2025-07-31 0001813744 2024-05-01 2024-07-31 0001813744 2023-11-01 2024-07-31 0001813744 us-gaap:PreferredStockMember 2024-10-31 0001813744 us-gaap:CommonStockMember 2024-10-31 0001813744 us-gaap:AdditionalPaidInCapitalMember 2024-10-31 0001813744 us-gaap:ComprehensiveIncomeMember 2024-10-31 0001813744 us-gaap:RetainedEarningsMember 2024-10-31 0001813744 us-gaap:PreferredStockMember 2025-01-31 0001813744 us-gaap:CommonStockMember 2025-01-31 0001813744 us-gaap:AdditionalPaidInCapitalMember 2025-01-31 0001813744 us-gaap:ComprehensiveIncomeMember 2025-01-31 0001813744 us-gaap:RetainedEarningsMember 2025-01-31 0001813744 2025-01-31 0001813744 us-gaap:PreferredStockMember 2025-04-30 0001813744 us-gaap:CommonStockMember 2025-04-30 0001813744 us-gaap:AdditionalPaidInCapitalMember 2025-04-30 0001813744 us-gaap:ComprehensiveIncomeMember 2025-04-30 0001813744 us-gaap:RetainedEarningsMember 2025-04-30 0001813744 2025-04-30 0001813744 us-gaap:PreferredStockMember 2024-11-01 2025-01-31 0001813744 us-gaap:CommonStockMember 2024-11-01 2025-01-31 0001813744 us-gaap:AdditionalPaidInCapitalMember 2024-11-01 2025-01-31 0001813744 us-gaap:ComprehensiveIncomeMember 2024-11-01 2025-01-31 0001813744 us-gaap:RetainedEarningsMember 2024-11-01 2025-01-31 0001813744 2024-11-01 2025-01-31 0001813744 us-gaap:PreferredStockMember 2025-02-01 2025-04-30 0001813744 us-gaap:CommonStockMember 2025-02-01 2025-04-30 0001813744 us-gaap:AdditionalPaidInCapitalMember 2025-02-01 2025-04-30 0001813744 us-gaap:ComprehensiveIncomeMember 2025-02-01 2025-04-30 0001813744 us-gaap:RetainedEarningsMember 2025-02-01 2025-04-30 0001813744 2025-02-01 2025-04-30 0001813744 us-gaap:PreferredStockMember 2025-05-01 2025-07-31 0001813744 us-gaap:CommonStockMember 2025-05-01 2025-07-31 0001813744 us-gaap:AdditionalPaidInCapitalMember 2025-05-01 2025-07-31 0001813744 us-gaap:ComprehensiveIncomeMember 2025-05-01 2025-07-31 0001813744 us-gaap:RetainedEarningsMember 2025-05-01 2025-07-31 0001813744 us-gaap:PreferredStockMember 2025-07-31 0001813744 us-gaap:CommonStockMember 2025-07-31 0001813744 us-gaap:AdditionalPaidInCapitalMember 2025-07-31 0001813744 us-gaap:ComprehensiveIncomeMember 2025-07-31 0001813744 us-gaap:RetainedEarningsMember 2025-07-31 0001813744 us-gaap:PreferredStockMember 2023-10-31 0001813744 us-gaap:CommonStockMember 2023-10-31 0001813744 us-gaap:AdditionalPaidInCapital 2023-10-31 0001813744 us-gaap:ComprehensiveIncomeMember 2023-10-31 0001813744 us-gaap:RetainedEarningsMember 2023-10-31 0001813744 2023-10-31 0001813744 us-gaap:PreferredStockMember 2024-01-31 0001813744 us-gaap:CommonStockMember 2024-01-31 0001813744 us-gaap:AdditionalPaidInCapital 2024-01-31 0001813744 us-gaap:ComprehensiveIncomeMember 2024-01-31 0001813744 us-gaap:RetainedEarningsMember 2024-01-31 0001813744 2024-01-31 0001813744 us-gaap:PreferredStockMember 2024-04-30 0001813744 us-gaap:CommonStockMember 2024-04-30 0001813744 us-gaap:AdditionalPaidInCapital 2024-04-30 0001813744 us-gaap:ComprehensiveIncomeMember 2024-04-30 0001813744 us-gaap:RetainedEarningsMember 2024-04-30 0001813744 2024-04-30 0001813744 us-gaap:PreferredStockMember 2023-11-01 2024-01-31 0001813744 us-gaap:CommonStockMember 2023-11-01 2024-01-31 0001813744 us-gaap:AdditionalPaidInCapital 2023-11-01 2024-01-31 0001813744 us-gaap:ComprehensiveIncomeMember 2023-11-01 2024-01-31 0001813744 us-gaap:RetainedEarningsMember 2023-11-01 2024-01-31 0001813744 2023-11-01 2024-01-31 0001813744 us-gaap:PreferredStockMember 2024-02-01 2024-04-30 0001813744 us-gaap:CommonStockMember 2024-02-01 2024-04-30 0001813744 us-gaap:AdditionalPaidInCapital 2024-02-01 2024-04-30 0001813744 us-gaap:ComprehensiveIncomeMember 2024-02-01 2024-04-30 0001813744 us-gaap:RetainedEarningsMember 2024-02-01 2024-04-30 0001813744 2024-02-01 2024-04-30 0001813744 us-gaap:PreferredStockMember 2024-05-01 2024-07-31 0001813744 us-gaap:CommonStockMember 2024-05-01 2024-07-31 0001813744 us-gaap:AdditionalPaidInCapital 2024-05-01 2024-07-31 0001813744 us-gaap:ComprehensiveIncomeMember 2024-05-01 2024-07-31 0001813744 us-gaap:RetainedEarningsMember 2024-05-01 2024-07-31 0001813744 us-gaap:PreferredStockMember 2024-07-31 0001813744 us-gaap:CommonStockMember 2024-07-31 0001813744 us-gaap:AdditionalPaidInCapital 2024-07-31 0001813744 us-gaap:ComprehensiveIncomeMember 2024-07-31 0001813744 us-gaap:RetainedEarningsMember 2024-07-31 0001813744 2024-07-31 0001813744 2023-11-01 2024-10-31 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 10-Q

[X] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

FOR THE QUARTERLY PERIOD ENDED July 31, 2025

[ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from to

COMMISSION FILE NUMBER: 000-56208

World Scan Project, Inc.

(Exact name of registrant as specified in its charter)

	DE	35-2677532
	(State or other jurisdiction of incorporation or organization)	(I.R.S. Employer Identification No.)

	2-18-23, Nishiwaseda Shinjuku-Ku, Tokyo, Japan	169-0051
	(Address of Principal Executive Offices)	(Zip Code)

Issuer's telephone number: +81-3-6670-1692

Email: contact@world-scan-project.com

Indicate by check mark whether the registrant (1) filed all reports required to be filed by Section 13 or 15(d) of the Exchange Act during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. [ ] Yes [X] No

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (Section 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). [ ] Yes [X] No

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act.

Large accelerated filer ☐		Accelerated filer ☐		Non-accelerated filer ☒
Smaller reporting company ☒		Emerging growth company ☒

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. [ ]

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).

[ ] Yes [X] No

Indicate the number of shares outstanding of each of the issuer’s classes of common stock, as of the latest practicable date.

As of September 23, 2025, there were 11,997,350 shares of common stock and 10,000,000 shares of preferred stock issued and outstanding.

-1-

INDEX

		Page
PART I - FINANCIAL INFORMATION

ITEM 1	FINANCIAL STATEMENTS - UNAUDITED	F1
Consolidated Balance Sheets - UNAUDITED		F1
CONSOLIDATED Statements of Operations AND COMPREHENSIVE INCOME- UNAUDITED		F2
cONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS’ EQUITY (DEFICIT)- UNAUDITED		F3
cONSOLIDATED Statement of Cash Flows - unaudited		F4
Notes to CONSOLIDATED Financial Statements - unaudited		F5

ITEM 2	MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITIONS AND RESULTS OF OPERATIONS	3
ITEM 3	QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK	3
ITEM 4	CONTROLS AND PROCEDURES	4

PART II - OTHER INFORMATION

ITEM 1	LEGAL PROCEEDINGS	5
ITEM 1A	RISK FACTORS
ITEM 2	UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS	5
ITEM 3	DEFAULTS UPON SENIOR SECURITIES	5
ITEM 4	MINE SAFETY DISCLOSURES	5
ITEM 5	OTHER INFORMATION	5
ITEM 6	EXHIBITS	5

SIGNATURES		6

-2-

Table of Contents

PART I - FINANCIAL INFORMATION

WORLD SCAN PROJECT, INC.

CONSOLIDATED BALANCE SHEETS

		July 31, 2025 (Unaudited)		October 31, 2024
ASSETS
Current Assets
Cash and cash equivalents	$	211,684	$	1,634,200
Accounts receivable, trade		309		902
Other receivables, current		1,823,797		1,070,404
Advance payments and prepaid expenses		396,213		4,636,258
Inventories		14,866,256		17,045,647
TOTAL CURRENT ASSETS		17,298,259		24,387,411
Non-current assets
Furniture, fixtures and equipment, net		4,132,955		212,200
Lease asset long term		520,347		677,022
Investment securities		1,606,533		1,562,093
Long term prepaid expenses and security deposits, net		64,429		49,071
Deferred tax assets		404,819		436,572
Other intangible assets, non-current		84,838		85,882
TOTAL NON-CURRENT ASSETS		6,813,921		3,022,840

TOTAL ASSETS	$	24,112,180	$	27,410,251

LIABILITIES AND SHAREHOLDERS' EQUITY
Current Liabilities
Accrued expenses and other payables	$	300,772	$	1,186,679
Accounts payable - related party		48,335		45,532
Income taxes payable		-		334,413
Consumption tax payable		-		13,882
Short-term lease liability		134,369		233,160
Advance received		1,027,979		3,391,942
Due to related party		458		458
Share application pending allotment		-		5,154,136
TOTAL CURRENT LIABILITIES		1,511,913		10,360,202

Non-Current Liabilities
Lease liability long term		406,897		466,643
Deferred revenue long term		39,372		-
TOTAL NON-CURRENT LIABILITIES		446,269		466,643

TOTAL LIABILITIES	$	1,958,182	$	10,826,845

Shareholders' Equity
Preferred stock ($0.0001 par value, 200,000,000 shares authorized; 10,000,000 shares issued and outstanding as of July 31, 2025 and October 31, 2024)	$	1,000	$	1,000
Common stock ($0.0001 par value, 200,000,000 shares authorized, 11,997,350 and 11,560,350 shares issued and outstanding as of July 31, 2025 and October 31, 2024, respectively)		1,200		1,156
Additional paid-in capital		15,873,803		10,629,847
Accumulated earnings		8,173,451		8,370,124
Accumulated other comprehensive income		(1,895,456)		(2,418,721)

TOTAL SHAREHOLDERS' EQUITY	$	22,153,998	$	16,583,406

TOTAL LIABILITIES AND SHAREHOLDERS' EQUITY	$	24,112,180	$	27,410,251

The accompanying notes are an integral part of these unaudited financial statements.

F-1

Table of Contents

WORLD SCAN PROJECT, INC.

CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE INCOME

(UNAUDITED)

		For the Three Months Ended July 31, 2025		For the Three Months Ended July 31, 2024		For the Nine Months Ended July 31, 2025		For the Nine Months Ended July 31, 2024

Revenues	$	1,585,499	$	2,100,399	$	10,257,153	$	12,956,465

Total Revenues		1,585,499		2,100,399		10,257,153		12,956,465
Cost of revenues		868,069		1,699,724		6,296,303		9,654,160
Gross profit	$	717,430	$	400,675	$	3,960,850	$	3,302,305

OPERATING EXPENSE
Research and development		188,298		318,858		513,328		630,500
General and administrative expenses		1,231,110		1,155,861		3,673,884		3,928,562
Total operating expenses		1,419,408		1,474,719		4,187,212		4,559,062

Income/(Loss) from operations		(701,978)		(1,074,044)		(226,362)		(1,256,757)

Other income/(expense)
Other income		5		-		322		11
Gain (loss) on disposal of assets		(19)		-		(1,307)		-
Other expense		235		(812)		(1,478)		(95,470)
Total other income/(expenses)		221		(812)		(2,463)		(95,459)

Net income (loss) before tax		(701,757)		(1,074,856)		(228,825)		(1,352,216)
Income tax expense/(credit)		(190,725)		(214,959)		(32,152)		(294,333)
NET INCOME/(LOSS)	$	(511,032)	$	(859,897)	$	(196,673)	$	(1,057,883)

OTHER COMPREHENSIVE INCOME/(LOSS)
Foreign currency translation adjustment	$	(1,090,416)	$	984,085	$	523,265	$	177,013

TOTAL COMPREHENSIVE INCOME/ (LOSS)	$	(1,601,448)	$	124,188	$	326,592	$	(880,870)

Income per common share
Basic	$	(0.04)	$	(0.08)	$	(0.02)	$	(0.10)
Diluted	$	(0.02)	$	(0.04)	$	(0.01)	$	(0.05)

Weighted average common shares outstanding
Basic		11,997,350		11,337,220		11,917,581		11,018,683
Diluted		21,997,350		21,337,220		21,917,581		21,018,683

The accompanying notes are an integral part of these unaudited financial statements.

F-2

Table of Contents

WORLD SCAN PROJECT, INC.

CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS' EQUITY (DEFICIT)

FOR THE PERIOD ENDING JULY 31, 2025

(UNAUDITED)

										ACCUMULATED
								ADDITIONAL		OTHER		ACCUMULATED		TOTAL
	PREFERRED STOCK			COMMON STOCK				PAID IN		COMPREHENSIVE		EARNINGS		EQUITY
	NUMBER		AMOUNT	NUMBER		AMOUNT		CAPITAL		INCOME (LOSS)		(DEFICIT)		(DEFICIT)

Balance - October 31, 2024	10,000,000	$	1,000	11,560,350	$	1,156	$	10,629,847	$	(2,418,721)	$	8,370,124	$	16,583,406

Common shares sold	-		-	437,000		44		5,243,956		-		-		5,244,000
Net income	-		-	-		-		-		-		101,969		101,969
Foreign currency translation	-			-		-		-		(206,910)		-		(206,910)
Balance – January 31, 2025	10,000,000	$	1,000	11,997,350	$	1,200	$	15,873,803	$	(2,625,631)	$	8,472,093	$	21,722,465
Net income	-		-	-		-		-		-		212,390		212,390
Foreign currency translation	-		-	-		-		-		1,820,591		-		1,820,591
Balance April 30, 2025	10,000,000	$	1,000	11,997,350	$	1,200	$	15,873,803	$	(805,040)	$	8,684,483	$	23,755,446
Net loss	-		-	-		-		-		-		(511,032)		(511,032)
Foreign currency translation	-		-	-		-		-		(1,090,416)		-		(1,090,416)
Balance - July 31, 2025	10,000,000	$	1,000	11,997,350	$	1,200	$	15,873,803	$	(1,895,456)	$	8,173,451	$	22,153,998

The accompanying notes are an integral part of these unaudited financial statements.

WORLD SCAN PROJECT, INC.

CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS’ EQUITY (DEFICIT)

FOR THE PERIOD ENDING JULY 30, 2024

(UNAUDITED)

								ADDITIONAL		ACCUMULATED OTHER		ACCUMULATED		TOTAL
	PREFERRED STOCK			COMMON STOCK				PAID IN		COMPREHENSIVE		EARNINGS		EQUITY
	NUMBER		AMOUNT	NUMBER		AMOUNT		CAPITAL		INCOME (LOSS)		(DEFICIT)		(DEFICIT)

Balance - October 31, 2023	10,000,000	$	1,000	10,817,350	$	1,082	$	2,063,973	$	(2,488,923)	$	9,138,555	$	8,715,687

Net loss	-		-	-		-		-		-		(308,261)		(308,261)
Foreign currency translation	-		-	-		-		-		213,187		-		213,187
Balance - January 31, 2024	10,000,000	$	1,000	10,817,350	$	1,082	$	2,063,973	$	(2,275,736)	$	8,830,294	$	8,620,613
Common shares sold	-		-	486,000		49		5,831,951		-		-		5,832,000
Net income	-		-	-		-		-		-		110,275		110,275
Foreign currency translation	-		-	-		-		-		(1,020,259)		-		(1,020,259)
Balance - April 30, 2024	10,000,000	$	1,000	11,303,350	$	1,131	$	7,895,924	$	(3,295,995)	$	8,940,569	$	13,542,629
Common shares sold	-		-	257,000		26		2,733,922		-		-		2,733,948
Net loss	-		-	-		-		-		-		(859,897)		(859,897)
Foreign currency translation	-		-	-		-		-		984,085		-		984,085
Balance - July 31, 2024	10,000,000	$	1,000	11,560,350	$	1,157	$	10,629,846	$	(2,311,910)	$	8,080,672	$	16,400,765

The accompanying notes are an integral part of these unaudited financial statements.

F-3

Table of Contents

WORLD SCAN PROJECT, INC.

CONSOLIDATED STATEMENT OF CASH FLOWS

(UNAUDITED)

		Nine Months Ended		Nine Months Ended
		July 31, 2025		July 31, 2024

CASH FLOWS FROM OPERATING ACTIVITIES
Net income	$	(196,673)	$	(1,057,883)
Adjustments to reconcile net loss to net cash provided by (used in) operating activities:
Depreciation and amortization		111,752		41,114
Amortization of long-term deposits		5,198		9,129
Lease expense		198,418		111,289
Changes in operating assets and liabilities:
Accounts receivable		618		103,669
Advance payments and other prepaid expense		4,347,106		(785,178)
Inventories		2,663,757		(14,323,563)
Other receivables		(612,439)		(6,256)
Other current assets		-		-
Deferred tax assets		44,164		(362,453)
Accrued expenses and other payables		(6,217,605)		1,855,287
Taxes payable		(358,128)		(27,343)
Advance received		(2,420,574)		3,200,898
ROU asset/liability		(200,927)		(207,261)
Net cash used in operating activities		(2,635,333)		(11,448,551)

CASH FLOWS FROM INVESTING ACTIVITIES
Cash paid for purchase of fixed assets		(4,021,282)		(33,823)
Cash paid for intangible assets		-		(571,646)
Net cash used in investing activities		(4,021,282)		(605,469)

CASH FLOWS FROM FINANCING ACTIVITIES
Proceeds from the sale of shares		5,244,000		8,565,948
Net cash provided by (used in) financing activities		5,244,000		8,565,948

Net effect of exchange rate changes on cash	$	(9,901)	$	(1,088,917)

Net Change in Cash and Cash Equivalents		(1,422,516)		(4,576,989)
Cash and cash equivalents - beginning of period		1,634,200		5,698,883
Cash and cash equivalents - end of period	$	211,684	$	1,121,894


SUPPLEMENTAL DISCLOSURES OF CASH FLOW INFORMATION
Interest paid	$	-	$	-
Income taxes paid	$	334,413	$	-

NON-CASH INVESTING AND FINANCING TRANSACTIONS
ROU Asset/Liability	$	-	$	-

The accompanying notes are an integral part of these unaudited financial statements.

F-4

Table of Contents

WORLD SCAN PROJECT, INC.

CONSOLIDATED NOTES TO FINANCIAL STATEMENTS

JULY 31, 2025

(UNAUDITED)

NOTE 1 - ORGANIZATION AND DESCRIPTION OF BUSINESS

World Scan Project, Inc., a Delaware corporation (“the Company”) was incorporated under the laws of the State of Delaware on October 25, 2019.

On October 25, 2019, Ryohei Uetaki, our officer and director, paid for expenses involved with the incorporation of the Company with personal funds on behalf of the Company, in exchange for 10,000,000 shares of Common Stock, par value $0.0001 per share and 10,000,000 shares of Series A Preferred stock, par value $0.0001 per share, which issuance was exempt from the registration provisions of Section 5 of the Securities Act under Section 4(2) of such same said act. The value of the stock provided to Mr. Uetaki, based on the par value of $.0001 per share of common stock and Series A Preferred Stock, is valued at $2,000.

On October 25, 2019, Ryohei Uetaki was appointed as Chief Executive Officer, Chief Financial Officer, President, Director, Secretary, and Treasurer.

On November 18, 2019, Yasumasa Ichikawa was appointed as Chief Technology Officer.

On January 25, 2020, the Company entered into and consummated a Share Contribution Agreement with Ryohei Uetaki. Pursuant to this agreement Mr. Uetaki gifted to the Company, at no cost, 300 shares of common stock of World Scan Project Corporation, a Japan corporation (“WSP Japan”), which represented all of its issued and outstanding shares. The Company has since gained a 100% interest in the issued and outstanding shares of WSP Japan’s common stock and WSP Japan is now a wholly owned subsidiary of the Company. The Company and WSP Japan were under common control at the time of the acquisition.

WSP Japan was incorporated under the laws of Japan on January 22, 2020. Currently, WSP Japan is headquartered in Tokyo, Japan. The Company’s primary business is focused on developing and manufacturing of autonomous aerial vehicles including drones.

On February 19, 2020, Ryohei Uetaki gifted 7,000,000 shares of our Common Stock and 10,000,000 shares of our Series A Preferred Stock, which represented all of our issued and outstanding shares of Preferred Stock at the time, to SKYPR LLC, a Delaware Limited Liability Company (referred to herein as “SKYPR LLC”). Our CEO Ryohei Uetaki owns and controls 100% of the membership interests in SKYPR LLC.

In September 2020, the Company entered into subscription agreements with 41 shareholders. Pursuant to these agreements, the Company issued 647,350 shares of common stock in total to these shareholders and received $323,675 as aggregate consideration. At the time of purchase the price paid per share by each shareholder was the equivalent of about 0.50 USD.

These shares were sold pursuant to the Company’s effective S-1 Registration Statement deemed effective on August 28, 2020 at 4pm EST.

In June and August of 2023, the Company entered into subscription agreements with 10 shareholders. Pursuant to these agreements, the Company issued 170,000 shares of Common Stock in total to these shareholders and received $1,740,000 as aggregate consideration. At the time of purchase the price paid per share by each shareholder was approximately 10.00 USD. These shares were sold pursuant to the Company’s effective S-1 Registration Statement deemed effective on May 25, 2023 at 4pm EST. This offering has been completed and is no longer ongoing.

However, offering deemed effective in August 2023 is still ongoing. On August 13, 2024, we filed a Form 8-K with the SEC to announce that Mr. Ryohei Uetaki had chosen to extend the offering period of the S-1 Registration Statement, which was declared effective by the Securities and Exchange Commission at 4:00 PM EST on August 23, 2023 by an additional 90 calendar days. As a result, the offering will now conclude on or about November 21, 2024.

We operate through our wholly owned subsidiary, World Scan Project Corporation, a Japanese Company. We are a start-up stage company currently focused on developing, designing and selling small sized drones which may be used for a variety of purposes.

Our principal executive offices are located at 2-18-23, Nishiwaseda, Shinjuku-Ku, Tokyo, 169-0051, Japan.

The Company has elected October 31^st as its year end.

NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

Principles of Consolidations

The consolidated financial statements include the accounts of the Company and its wholly owned subsidiary, World Scan Project Corporation, whose registered address is 2-18-23, Nishiwaseda, Shinjuku-Ku, Tokyo, 162-0051, Japan. All significant intercompany accounts and transactions have been eliminated.

Basis of Presentation

This summary of significant accounting policies is presented to assist in understanding the Company’s financial statements. These accounting policies conform to accounting principles, generally accepted in the United States of America, and have been consistently applied in the preparation of the financial statements.

Reclassification

Certain amounts in the prior period have been reclassified to conform to the current period presentation.

Use of Estimates

The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. In the opinion of management, all adjustments necessary in order to make the financial statements not misleading have been included. Actual results could differ from those estimates.

Advertising and Promotion

All advertising, promotion and marketing expenses, including commissions, are expensed when incurred.

Leases

The Company capitalizes all leased assets pursuant to ASU 2016-02, Leases (Topic 842) (“Topic 842”), which requires lessees to recognize right-of-use (“ROU”) assets and lease liability, initially measured at present value of the lease payments, on its balance sheet for leases with terms longer than 12 months and classified as either financing or operating leases. The Company excludes short-term leases having initial terms of 12 months or less from Topic 842 as an accounting policy election and recognizes rent expense on a straight-line basis over the lease term.

Related party transaction

A related party is generally defined as (i) any person that holds 10% or more of the Company’s securities and their immediate families, (ii) the Company’s management, (iii) someone that directly or indirectly controls, is controlled by or is under common control with the Company, or (iv) anyone who can significantly influence the financial and operating decisions of the Company. A transaction is considered to be a related party transaction when there is a transfer of resources or obligations between related parties. The Company conducts business with its related parties in the ordinary course of business.

Transactions involving related parties cannot be presumed to be carried out on an arm’s-length basis, as the requisite conditions of competitive, free market dealings may not exist. Representations about transactions with related parties, if made, shall not imply that the related party transactions were consummated on terms equivalent to those that prevail in arm’s-length transactions unless such representations can be substantiated.

Cash and Cash Equivalents

The Company considers all highly liquid investments with an original maturity of nine months or less when purchased to be cash equivalents.

Accounts Receivable and Credit Policies

Accounts receivable are recognized and carried at the original invoice amount less allowance for any uncollectible amounts. An estimate for doubtful accounts is made when collection of the full amount is no longer probable. Bad debts are written off as incurred. If there is a claim for a defect of product within four days after arrival of goods, the Company shall accept a goods return.

Advance payments and prepaid expenses

Advance payments and prepaid expenses are cash paid amounts that represent costs incurred from which a service or benefit is expected to be derived in the future.

Inventory

Inventories, consisting of products available for sale, are primarily accounted for using the first-in, first-out (“FIFO”) method, and are valued at the lower of cost or market value. This valuation requires the Company to make judgments, based on currently-available information, about the likely method of disposition, such as through sales to individual customers, returns to product vendors, or liquidations, and expected recoverable values of each disposition category.

Fixed assets and depreciation

Property, plant and equipment are stated at cost less depreciation and impairment loss. The initial cost of the assets comprises its purchase price and any directly attributable costs of bringing the asset to its working condition and location for its intended use. Depreciation is calculated using the straight-line method over the shorter of the estimated useful life of the respective assets as follows: computer software developed or acquired for internal use, 5 years; leasehold improvements, 10 years; and tools, furniture and fixtures, 2 to 15 years.

Investment and Securities

In accordance with ASC 321-10-35-2, the Company elected to measure an equity security without a readily determinable fair value at its cost subject to impairment. The Company has not identified any observable price changes in orderly transactions for the identical or a similar investment of the same issuer.

F-5

Table of Contents

Foreign currency translation

The Company maintains its books and records in its local currency, Japanese YEN (“JPY”), which is a functional currency as being the primary currency of the economic environment in which its operation is conducted. Transactions denominated in currencies other than the functional currency are translated into the functional currency at the exchange rates prevailing at the dates of the transaction. Monetary assets and liabilities denominated in currencies other than the functional currency are translated into the functional currency using the applicable exchange rates at the balance sheet dates. The resulting exchange differences are recorded in the statements of operations.

The reporting currency of the Company is the United States Dollars (“US$”) and the accompanying consolidated financial statements have been expressed in US$. In accordance with ASC Topic 830-30, “Translation of Financial Statement”, assets and liabilities of the Company whose functional currency is not US$ are translated into US$, using the exchange rate on the balance sheet date. Revenues and expenses are translated at weighted average quarterly rates prevailing during the period. The gains and losses resulting from translation of financial statements are recorded as a separate component of accumulated other comprehensive income within the statements of shareholders’ equity.

Comprehensive income or loss

ASC Topic 220, “Comprehensive Income”, establishes standards for reporting and display of comprehensive income or loss, its components and accumulated balances. Comprehensive income or loss as defined includes all changes in equity during a period from non-owner sources. Accumulated comprehensive income, as presented in the accompanying consolidated statements of shareholders’ equity consists of changes in unrealized gains and losses on foreign currency translation.

Revenue recognition

The Company adopted ASC 606 – Revenue from contracts with Customers: (1) identify the contract with a customer; (2) identify the performance obligations in the contract; (3) determine the transaction price; (4) allocate the transaction price to each performance obligation in the contract; and (5) recognize revenue when each performance obligation is satisfied.

Revenue amount represents the invoiced value, net of a value-added tax (“Consumption Tax”) and applicable local government levies. The Consumption Tax on sales is calculated at 10% of gross sales. The Company is subject to consumption taxes in Japan for the quarter ended July 31, 2025.

Revenue from product sales

Revenue for products is recognized when the products are delivered to the customer and the customer completes the product inspection. Cash receipts for undelivered products are recorded as advance received . As of July 31, 2025, advances received of $1,027,979 are related to product sales.

Revenue from educational institution program

Revenue for educational institution fees is recognized when the services are provided to the customer. Cash receipts for undelivered products are recorded as advance received. As of July 31, 2025, the Company had no advance received related to the educational institution program.

Other intangible assets

Other intangible assets with finite useful lives consist primarily of software, which are amortized using the straight-line method. The costs incurred for the development of computer software to be sold, leased, or otherwise marketed are capitalized in accordance with ASC 985-20, Costs of Software to be Sold, Leased or Marketed, when technological feasibility has been established.

Research and Development

The Company accounts for research and development costs in accordance with ASC subtopic 730-10, Research and Development (“ASC 730-10”).

Under ASC 730-10, all research and development costs must be expensed------------------------------------------------------- as incurred. Accordingly, internal research and development costs are expensed as incurred. Third-party research and development costs are expensed when the contracted work has been performed or as milestone results have been achieved as defined under the applicable agreement.

The Company also applies the principles of ASC 985-20, Accounting for the Costs of Computer Software to Be Sold, Leased, or Otherwise Marketed (“ASC 985-20”). ASC 985-20 requires that software development costs incurred in conjunction with product development be charged to research and development expense until technological feasibility is established.

The Company records expenses for research and development activities based on Management’s estimates of services received and efforts expended pursuant to contracts with vendors that conduct research and development on the Company’s behalf. The financial terms vary from contract to contract and may result in uneven payment flows as compared with services performed or products delivered. As a result, the Company is required to estimate research and development expenses incurred during the period, which impacts the amount of Advance payments and prepaid expenses balances related to such costs as of each balance sheet date. Management estimates the amount of work completed through discussions with internal personnel and the contract research and contract manufacturing entity as to the progress or stage of completion of the services. The Company’s estimates are based on a number of factors, including the Company’s knowledge of the status of each of the research and development project milestones.

Income Taxes

The Company accounts for income taxes under ASC 740, “Income Taxes.” Under the asset and liability method of ASC 740, deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial statements carrying amounts of existing assets and liabilities and their respective tax bases. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period the enactment occurs. A valuation allowance is provided for certain deferred tax assets if it is more likely than not that the Company will not realize tax assets through future operations. The Company recognized deferred tax assets of $404,819 and $436,572 as of July 31, 2025 and October 31, 2024, respectively.

Basic Earnings (Loss) Per Share

The Company computes basic and diluted earnings (loss) per share in accordance with ASC Topic 260, Earnings per Share. Basic earnings (loss) per share is computed by dividing net income (loss) by the weighted average number of common shares outstanding during the reporting period. Diluted earnings (loss) per share reflects the potential dilution that could occur if stock options and other commitments to issue common stock were exercised or equity awards vest resulting in the issuance of common stock that could share in the earnings of the Company. Each shareholder of Series A Preferred Stock may convert their shares at the option of the holder thereof into an equal amount of shares of any other class or series of the Company’s stock on a one to one basis, therefore the Company computes diluted earnings (loss) per shares by dividing net income (loss) by the sum of the total of weighted average number of common shares and total preferred shares outstanding.

Basic and diluted earnings per share or the three and nine months ended July 31^st are as follows:

		Three months ended July 31, 2025		Three months ended July 31, 2024	Nine months ended July 31, 2025		Nine Months ended July 31, 2024
Basic earnings per share	$	(0.04)	$	(0.08)	$	(0.02)	$	(0.10)
Diluted earnings per share	$	(0.02)	$	(0.04)	$	(0.01)	$	(0.05)

Fair Value of Financial Instruments

The Company’s balance sheet includes certain financial instruments. The carrying amounts of current assets and current liabilities approximate their fair value because of the relatively short period of time between the origination of these instruments and their expected realization.

ASC 820, Fair Value Measurements and Disclosures, defines fair value as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. ASC 820 also establishes a fair value hierarchy that distinguishes between (1) market participant assumptions developed based on market data obtained from independent sources (observable inputs) and (2) an entity’s own assumptions about market participant assumptions developed based on the best information available in the circumstances (unobservable inputs). The fair value hierarchy consists of three broad levels, which gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1) and the lowest priority to unobservable inputs (Level 3). The three levels of the fair value hierarchy are described below:

- Level 1 – Unadjusted quoted prices in active markets that are accessible at the measurement date for identical, unrestricted assets or liabilities.

- Level 2 – Inputs other than quoted prices included within Level 1 that are observable for the asset or liability, either directly or indirectly, including quoted prices for similar assets or liabilities in active markets; quoted prices for identical or similar assets or liabilities in markets that are not active; inputs other than quoted prices that are observable for the asset or liability (e.g., interest rates); and inputs that are derived principally from or corroborated by observable market data by correlation or other means.

- Level 3 – Inputs that are both significant to the fair value measurement and unobservable.

Recently Issued Accounting Pronouncements

The Company does not believe that any recently issued effective pronouncements, or pronouncements issued but not yet effective, if adopted, would have a material effect on the accompanying financial statements.

Concentration of Purchases

Net purchase from suppliers accounting for 10% or more of total purchases are as follows:

For the period ended July 31, 2025, 34.73% of the inventories were purchased from Bon Corporation in the amount of $2,186,831.

For the period ended July 31, 2025, 27.21% of the inventories were purchased from Handa Boseki Co., Ltd in the amount of $1,713,491.

For the period ended July 31, 2025, 17.70% of the inventories were purchased from G-Force, Inc. in the amount of $1,114,344.

For the period ended July 31, 2025, 11.58% of the inventories were purchased from Osaka Orikomi Co., Ltd in the amount of $728,944.

For the period ended July 31, 2024, 24.25% of the inventories were purchased from MUSASHI Inc. in the amount of $2,361,582.

For the period ended July 31, 2024, 22.69% of the inventories were purchased from Web3 Computing Corp in the amount of $2,213,158.

For the period ended July 31, 2024, 20.99% of the inventories were purchased from CU Holdings Co., Ltd in the amount of $2,026,834.

Concentration of Revenues

Revenues from customers accounting for 10% or more of total revenues are as follows:

For the period ended July 31, 2025, 33.28% of total revenue was generated from Drone Net.in the amount of $3,413,159.

For the period ended July 31, 2024, 23.34% of total revenue was generated from I’rom Co. Ltd., in the amount of $3,088,481.

For the period ended July 31, 2024, 13.89% of total revenue was generated from TSUBOI Industries Co., Ltd. in the amount of $1,788,528.

For the period ended July 31, 2024, 11.42% of total revenue was generated from Drone Net, Inc., in the amount of $1,484,355.

For the period ended July 31, 2024, 11.39% of total revenue was generated from Naniwa Co., Ltd, in the amount of $1,406,205.

F-6

Table of Contents

NOTE 3 - ACCOUNTS RECEIVABLE

Accounts receivable from customers totaled $309 as of July 31, 2025 and $902 as of October 31, 2024. No bad debt allowance was provided as of July 31, 2025 and October 31, 2024.

Concentration of Accounts Receivable

Accounts receivable from customers accounting for 10% or more of total accounts receivable are as follows:

For the period ended July 31, 2025, 100% of total accounts receivable was owed to the Company by Sanyukai Medical Corp in the amount of $309.

As of October 31, 2024, 100% of total accounts receivable was owed to the Company by Sanyukai Medical Corp in the amount of $902.

NOTE 4 - ADVANCE PAYMENTS AND PREPAID EXPENSES

Advance payments are comprised of the payments for the undelivered products and other deliverables. As of July 31, 2025 and October 31, 2024, the Company had advance payments and other prepaid expenses of $396,213 and $4,636,258, respectively. Details of the advance payments as of July 31, 2025 and October 31, 2024 are as follows:

		July 31, 2025		October 31, 2024
Purchase of product from Rogyx Co., Ltd	$	76,726	$	67,401
Purchase of products from Sankyu Co., Ltd		28,805		28,009
Purchase of products from I’rom Group Co., Ltd		155,305		134,438
Purchase of cryptocurrency miners from Web3 Computing Corp		-		4,295,746
Other advances and prepaid expenses		135,377		110,654
Totals	$	396,213	$	4,636,258

NOTE 5 - FIXED ASSETS

The company recognizes purchased assets with a useful life longer than one year as fixed or non-current assets. These assets are depreciated using the straight-line method of depreciation over the estimated useful life of the assets.

During the period ended July 31, 2025, the Company purchased additional long-term assets totaling $4,021,282. The Company is depreciating previously purchased assets over a 1-15 year period once they were put into use. Depreciation expense for the periods ended July 31, 2025 and July 31, 2024 were $111,752 and $41,114, respectively.

During the year ended October 31, 2024, the Company purchased additional long-term assets totaling $1,218,854, including software. The Company is depreciating fixed assets over a 1-39 year period once they were put into use. Depreciation expense for the year ended October 31, 2024 was $1,251,414.

NOTE 6 - ADVANCE RECEIVED

Advance received is the amount the Company received in advance from the customer for their orders placed with us. As of July 31, 2025 advance received in the amount of $1,027,979 was mainly related to our sales of cryptocurrency miners which represents a large amount in both number of transactions and values. As of October 31, 2024, advance received in the amount of $3,391,942 was related to our sales of cryptocurrency miners which represents a large amount in both number of transactions and values.

NOTE 7 - REVENUE

The following table summarizes our revenue recognized under ASC 606 in our consolidated statements of operations:

	Nine Months Ended
	July 31,
	2025		2024

Revenues
Product sales	$	10,192,098	$	12,956,465
Drone imaging/video		39,486		-
Other		25,569		-
Total Revenue Under ASC 606	$	10,257,153	$	12,956,465

NOTE 8 - RESEARCH & DEVELOPMENT

During the periods ended July 31, 2025 and 2024, the Company incurred research and development expenses of $513,328 and $630,500, respectively, for products the Company intends to offer for sale in the future.

NOTE 9 - INCOME TAXES

For the periods ended July 31, 2025 and 2024, the Company had income tax credits of $32,152 and $294,333, respectively.

United States

The Company was incorporated under the laws of the State of Delaware on October 25, 2019. The U.S. federal income tax rate is 21%.

Japan

The Company conducts its major businesses in Japan through WSP Japan and is subject to tax in this jurisdiction. As a result of its business activities, the Company files tax returns that are subject to examination by the local tax authority.

The realization of deferred tax assets is dependent upon the generation of sufficient taxable income of the appropriate character in future periods. The Company regularly assesses the ability to realize its deferred tax assets and establish a valuation allowance if it is more likely than not that some portion of the deferred tax assets will not be realized. The Company weighs all available positive and negative evidence, including its earnings history and results of recent operations, projected future taxable income, and tax planning strategies.

The amount of the deferred tax asset considered realizable, however, could be adjusted if estimates of future taxable income during the carryforward period are reduced or increased or if objective negative evidence in the form of cumulative losses is no longer present and additional weight may be given to subjective evidence such as the Company’s projections for growth. The adjustments of a valuation allowance against deferred tax assets may cause greater volatility in the effective tax rate in the periods in which the valuation allowance is adjusted. For the year ended October 31, 2021, a full valuation allowance was provided. For the year ended October 31, 2022, certain valuation allowance was released for WSP Japan considering the collectability of deferred tax assets.

For the periods ended July 31, 2025 and 2024, the Company’s income tax expenses are as follows:

	Nine Months Ended
	July 31,
	2025		2024
Current	$	76,316	$	73,072
Deferred		(44,164)		(367,405)
Total	$	(32,152)	$	(294,333)

As of July 31, 2025 and October 31, 2024, the Company had income tax payable of $0 and $334,413, respectively.

NOTE 10 - SHAREHOLDERS EQUITY

Preferred Stock

The authorized preferred stock of the Company consists of 200,000,000 shares with a par value of $0.0001. The authorized Series A Preferred Stock of the Company consists of 100,000,000. There were 10,000,000 shares of Series A Preferred Stock issued and outstanding as of July 31, 2025 and October 31, 2024.

The rights, preferences, privileges, restrictions and other matters relating to the Series A Preferred Stock are as follows:

(a) Each share of Series A Preferred Stock shall have no voting rights;

(b) Each shareholder of Series A Preferred Stock may convert their shares at the option of the holder thereof into an equal amount of shares of any other class or series of the Company’s stock on a one to one basis.

Common Stock

The authorized common stock of the Company consists of 200,000,000 shares with a par value of $0.0001. There were 11,997,350 and 11,560,350 shares of common stock issued and outstanding as of July 31, 2025 and October 31, 2024, respectively.

During the period ended July 31, 2025, 437,000 shares of common stock were issued to 31 shareholders for proceeds totaling $5,244,000 by an S-1 offering deemed effective on August 23, 2023 and extended to November 2024.

During the year ended October 31, 2024, 743,000 shares of common stock were issued to 43 shareholders for proceeds totaling $8,565,948 by an S-1 offering deemed effective on August 23, 2023 and extended to November 2024.

NOTE 11 - RELATED-PARTY TRANSACTIONS

Loan to the Company

As of July 31, 2025, our CEO and Director, Ryohei Uetaki, has advanced to the Company $48,335 for salary and $458 for expenses. This advance is considered as a loan to the Company, which is unsecured, noninterest-bearing and payable on demand.

As of October 31, 2024, our CEO and Director, Ryohei Uetaki, has advanced to the Company $45,532 for salary and $458 for expenses. This advance is considered as a loan to the Company which is unsecured, noninterest-bearing and payable on demand.

NOTE 12 - LEASE ASSETS AND LIABILITIES

Our adoption of ASU 2016-02, Leases (Topic 842), and subsequent ASUs related to Topic 842, requires us to recognize substantially all leases on the balance sheet as an ROU asset and a corresponding lease liability. The new guidance also requires additional disclosures as detailed below. We adopted this standard on the effective date of November 1, 2020 and used this effective date as the date of initial application. Under this application method, we were not required to restate prior period financial information or provide Topic 842 disclosures for prior periods. We elected the ‘package of practical expedients,’ which permitted us to not reassess our prior conclusions related to lease identification, lease classification, and initial direct costs, and we did not elect the use of hindsight.

We determine if a contract is a lease at the inception of the arrangement. We review all options to extend, terminate, or purchase the ROU assets, and when reasonably certain to exercise, we include the option in the determination of the lease term and lease liability. We have six operating leases related to our office space in Tokyo with remaining lease terms of 1 to over 3 years. We recognized $198,418 and $111,289 in operating lease costs for the nine months ended July 31, 2025 and July 31, 2024, respectively.

Lease ROU assets and liabilities are recognized at commencement date of the lease, based on the present value of lease payments over the lease term. The lease ROU asset also includes any lease payments made and excludes any lease incentives. When readily determinable, we use the implicit rate in determining the present value of lease payments. When leases do not provide an implicit rate, we use our incremental borrowing rate based on the information available at the lease commencement date, including the lease term.

The tables below present financial information associated with our leases. As noted above, we adopted Topic 842 using a transition method that does not require application to periods prior to adoption.

	Balance Sheet Classification		July 31, 2025		October 31, 2024

Right-of-use assets	Lease asset long	$	520,347	$	677,022
Current lease liabilities	Short-term lease liability		134,369		233,160
Non-current lease liabilities	Lease liability long term		406,897		466,643

Maturities of lease liabilities as of July 31, 2025 are as follows:

2025	231,967
2026	88,757
2027	73,087
2028 and beyond	302,412
Total	696,223
Add/(Less): Imputed interest	(154,957)

Present value of lease liabilities	541,266

NOTE 13 - ACCRUED EXPENSES AND OTHER PAYABLES

Accrued expenses and other payables are comprised of trade accounts payable, accrued payroll tax liabilities and accrued expenses. As of July 31, 2025 and October 31, 2024, the Company had accrued expenses and other payables of $300,772 and $1,186,679, respectively. Details of the accrued expenses and other payables as of July 31, 2025 and October 31, 2024 are as follows:

		July 31, 2025		October 31, 2024
Accounts payable, trade	$	212,100	$	1,109,345
Accounts payable for employees		52,703		63,631
Accrued payroll liabilities		35,969		13,703
Totals	$	300,772	$	1,186,679

NOTE 14 - SUBSEQUENT EVENTS

The Company has evaluated subsequent events through September 23, 2025, the date on which the consolidated financial statements were available to be issued and has found no material transactions to report.

F-7

Table of Contents

ITEM 2

MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

Forward-Looking Statements

Certain statements, other than purely historical information, including estimates, projections, statements relating to our business plans, objectives, and expected operating results, and the assumptions upon which those statements are based, are “forward-looking statements.”

These forward-looking statements generally are identified by the words “believes,” “project,” “expects,” “anticipates,” “estimates,” “intends,” “strategy,” “plan,” “may,” “will,” “would,” “will be,” “will continue,” “will likely result,” and similar expressions.

Forward-looking statements are based on current expectations and assumptions that are subject to risks and uncertainties which may cause actual results to differ materially from the forward-looking statements. Our ability to predict results or the actual effect of future plans or strategies is inherently uncertain. Factors which could have a material adverse effect on our operations and future prospects on a consolidated basis include but are not limited to: changes in economic conditions, legislative/regulatory changes, availability of capital, interest rates, competition, and generally accepted accounting principles. These risks and uncertainties should also be considered in evaluating forward-looking statements and undue reliance should not be placed on such statements.

Company Overview

Corporate History

World Scan Project, Inc., a Delaware corporation (“the Company”) was incorporated under the laws of the State of Delaware on October 25, 2019.

On October 25, 2019, Ryohei Uetaki was appointed as Chief Executive Officer, Chief Financial Officer, President, Director, Secretary, and Treasurer.

On November 18, 2019, Yasumasa Ichikawa was appointed as Chief Technology Officer.

These shares were sold pursuant to the Company’s effective S-1 Registration Statement deemed effective on August 28, 2020 at 4pm EST.

On August 13, 2024, we filed a Form 8-K with the SEC to announce that Mr. Ryohei Uetaki had chosen to extend the offering period of the S-1 Registration Statement, which was declared effective by the Securities and Exchange Commission at 4:00 PM EST on August 23, 2023 by an additional 90 calendar days. As a result, the offering concluded on November 21, 2024.

We operate through our wholly owned subsidiary, World Scan Project Corporation, a Japanese Company. The Company is an industrial automation equipment manufacturer, designing/developing robots, drones, Web3 infrastructure, IoT equipment and other related products.

Our principal executive offices are located at 2-18-23, Nishiwaseda, Shinjuku-Ku, Tokyo, 169-0051, Japan.

Liquidity and Capital Resources

As of July 31, 2025 we had cash and cash balance in the amount of $211,684. Currently, our cash balance is sufficient to fund our operations without the need for additional funding.

Revenues

We recorded revenues of $10,257,153 for the nine months ended July 31, 2025. We recorded revenues of $12,956,465 for the nine months ended July 31, 2024. This decrease in revenues was due mainly to a decrease in the sales of crypto miners.

Net Income

We recorded net loss of $196,673 for the nine months ended July 31, 2025. We recorded net loss of $1,057,883 for the nine months ended July 31, 2024. This decrease in net loss was due mainly to a decrease in the cost of goods sold and a decrease in general and administrative expenses.

Cash flow

For the nine months ended July 31, 2025, we had negative cash flows used in operations in the amount of $2,635,333. The decrease in operating cash flow is attributed to a decrease in accounts payable and accruals, partially offset by a decrease in advance payments and prepaid expenses, during this period. For the nine months ended July 31, 2025, we had cash flows used in investing activities in the amount of $4,021,282 due to the purchase of fixed assets. For the nine months ended July 31, 2025, we had cash flows from financing activities, totaling $5,244,000, from cash received from the sales of common shares.

ITEM 3

QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

As a smaller reporting company, as defined in Rule 12b-2 of the Exchange Act, we are not required to provide the information called for by this Item.

-3-

Table of Contents

ITEM 4

CONTROLS AND PROCEDURES

Management’s Report on Disclosure Controls and Procedures

We maintain disclosure controls and procedures that are designed to ensure that information required to be disclosed in our reports filed under the Securities Exchange Act of 1934, as amended, is recorded, processed, summarized and reported within the time periods specified in the Securities and Exchange Commission's rules and forms, and that such information is accumulated and communicated to our management, including our chief executive officer and our chief financial officer (who is acting as our principal executive officer, principal financial officer and principle accounting officer) to allow for timely decisions regarding required disclosure.

As of January 31, 2025, we carried out an evaluation, under the supervision of our chief executive officer, with the participation of our chief financial officer, of the effectiveness of the design and the operation of our disclosure controls and procedures. The officers concluded that the disclosure controls and procedures were not effective as of the end of the period covered by this report due to material weaknesses identified below.

The matters involving internal controls and procedures that our management considered to be material weaknesses under the standards of the Public Company Accounting Oversight Board were: domination of management by a single individual without adequate compensating controls, lack of a majority of outside directors on board of directors, resulting in ineffective oversight in the establishment and monitoring of required internal controls and procedures; inadequate segregation of duties consistent with control objectives, and lack of an audit committee. These material weaknesses were identified by our Chief Executive Officer, who also serves as our Chief Financial Officer in connection with the above evaluation.

Inherent limitations on effectiveness of controls

Internal control over financial reporting has inherent limitations which include but is not limited to the use of independent professionals for advice and guidance, interpretation of existing and/or changing rules and principles, segregation of management duties, scale of organization, and personnel factors. Internal control over financial reporting is a process which involves human diligence and compliance and is subject to lapses in judgment and breakdowns resulting from human failures. Internal control over financial reporting also can be circumvented by collusion or improper management override. Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements on a timely basis, however these inherent limitations are known features of the financial reporting process and it is possible to design into the process safeguards to reduce, though not eliminate, this risk. Therefore, even those systems determined to be effective can provide only reasonable assurance with respect to financial statement preparation and presentation. Projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.

Changes in Internal Control over Financial Reporting

There have been no changes in our internal controls over financial reporting that have occurred for the fiscal quarter ended January 31, 2025, that have materially or are reasonably likely to materially affect, our internal controls over financial reporting.

-4-

Table of Contents

PART II-OTHER INFORMATION

ITEM 1

LEGAL PROCEEDINGS

There are no legal proceedings against the Company and the Company is unaware of such proceedings contemplated against it.

ITEM 1A

RISK FACTORS

As a smaller reporting company, as defined in Rule 12b-2 of the Exchange Act, we are not required to provide the information called for by this Item.

ITEM 2

UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS

On October 25, 2019 the Company issued 10,000,000 shares of restricted Common Stock to Ryohei Uetaki for services rendered to the Company. Additionally, on the same day, it issued 10,000,000 shares of its restricted Series A Preferred Stock to Ryohei Uetaki, also for services rendered. The aforementioned shares of common and preferred stock were all issued at par value, $0.0001, having a total value of $2,000. No monies were exchanged per the issuances and the shares were all exempt from the registration provisions of Section 5 of the Securities Act under Section 4(2) of such same said act.

Uses of Proceeds from Registered Securities

In September, 2020, the Company entered into subscription agreements with 41 shareholders. Pursuant to these agreements, the Company issued 647,350 shares of common stock in total to these shareholders and received $323,675 as aggregate consideration. At the time of purchase, the price paid per share by each shareholder was the equivalent of about 0.50 USD.

These shares were sold pursuant to the Company’s effective S-1 Registration Statement deemed effective on August 28, 2020 at 4pm EST. On August 13, 2024, we filed a Form 8-K with the SEC to announce that Mr. Ryohei Uetaki had chosen to extend the offering period of the S-1 Registration Statement, which was declared effective by the Securities and Exchange Commission at 4:00 PM EST on August 23, 2023 by an additional 90 calendar days. As a result, the offering concluded on November 21, 2024. The Company will continue to provide investors with a current prospectus, including up-to-date financial information and any other required disclosures.

These funds are planned to be used for R&D, marketing and working capital.

ITEM 3

DEFAULTS UPON SENIOR SECURITIES

None.

ITEM 4

MINE SAFETY DISCLOSURES

Not applicable.

ITEM 5

OTHER INFORMATION

None.

ITEM 6

EXHIBITS

Exhibit No.		Description
3.1		Certificate of Incorporation (1)

3.2		By-laws (1)

31		Certification of the Company’s Principal Executive and Principal Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002, with respect to the registrant’s report on Form 10-Q for the period ended July 31, 2025 (2)

32		Certification of the Company’s Principal Executive and Principal Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 (2)

101.INS		Inline XBRL Instance Document (the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document).

101.SCH		Inline XBRL Taxonomy Extension Schema Document.

101.CAL		Inline XBRL Taxonomy Extension Calculation Linkbase Document.

101.DEF		Inline XBRL Taxonomy Extension Definition Linkbase Document.

101.LAB		Inline XBRL Taxonomy Extension Labels Linkbase Document.

101.PRE		Inline XBRL Taxonomy Extension Presentation Linkbase Document.

104		Cover Page Interactive Data File (embedded within the Inline XBRL document).

(1)	Filed as an exhibit to the Company's Registration Statement on Form S-1, as filed with the SEC on August 26, 2020, and incorporated herein by this reference.
(2)	Filed herewith.

-5-

Table of Contents

SIGNATURES

In accordance with the requirements of the Exchange Act, the registrant caused this report to be signed on its behalf by the undersigned, there unto duly authorized.

World Scan Project, Inc.

(Registrant)

By: /s/ Ryohei Uetaki

Name: Ryohei Uetaki

Chief Executive Officer and Chief Financial Officer

Dated: September 23, 2025

-6-

World Scan Project, Inc. 10-Q